Subscribe to our Newsletters !!

    worldwide pharma news

    Eppendorf AG Reports a Successful Financial Year 2019

    For the Eppendorf Group, an all inclusive dynamic life science organization, 2019 end up being an awesome financial year. Solidified income rose to €803.9 million (earlier year: €729.2 million), relating to an income increment from working business of 10.2% contrasted and a similar period a year ago. Natural development estimated in neighborhood monetary forms totalled